Found 4 results

Name Type of Offering Accepted Date
DalCor Pharmaceuticals US, LLC
D 2016-05-13
Amount To Be Raised $110,000,000
Associated Brokers / Dealers N/A
CIK Number 0001673368
Filed Document 0001673372-16-000001
Exclusions or Exemptions 506b
Accepted Date 2016-05-13
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
DalCor Pharmaceuticals US, LLC
D 2020-05-27 13:29:27
Amount To Be Raised $2,845,541
Associated Brokers / Dealers N/A
CIK Number 0001673368
Filed Document 0001673368-20-000001
Exclusions or Exemptions 506b
Accepted Date 2020-05-27 13:29:27
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business FLORIDA
Revenue or Assets Decline to Disclose
Type of Security Equity
DalCor Pharmaceuticals US, LLC
D/A 2017-05-12 12:14:00
Amount To Be Raised $110,000,000
Associated Brokers / Dealers N/A
CIK Number 0001673368
Filed Document 0001673368-17-000001
Exclusions or Exemptions 506b
Accepted Date 2017-05-12 12:14:00
Type of Offering D/A
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
DalCor Pharmaceuticals US, LLC
D/A 2020-09-14 14:21:35
Amount To Be Raised $3,851,699
Associated Brokers / Dealers N/A
CIK Number 0001673368
Filed Document 0001673368-20-000002
Exclusions or Exemptions 506b
Accepted Date 2020-09-14 14:21:35
Type of Offering D/A
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business FLORIDA
Revenue or Assets Decline to Disclose
Type of Security Equity